Plenty of brands are already sharing or teasing their Super Bowl 2026 ads. Here are all the commercials we've seen so far ...
Welcome to SolarBalls! Enjoy entertaining animations that teach you about the solar system and the universe. This channel features space animations infused with comedy, appealing to fans of both ...
Inquirer Business on MSN

Get ready for ‘Next Asian Wave’

MANILA, Philippines — No stress, and an “unapologetic energy” with East Asian influences—this is the vibe that consumers are ...
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...
Calocurb is a natural, prescription-free supplement designed to suppress appetite and reduce calorie intake. The supplement works by naturally supporting GLP-1 activation using an extract from New ...
Summer Kessel is a Registered Dietitian and Certified Specialist in Obesity and Weight Management. She is currently serving as cofounder and chief of operations, Community & Nutrition at Vineyard, a ...
Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...
Novo Nordisk operates in the pharmaceutical sector, with core franchises in diabetes care and obesity care supported by a ...
As the number of consumers using weight loss drugs grows — with 23% of U.S. households reporting someone on GLP-1 medications, according to Circana data from September 2025 — the foodservice industry ...
Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found. This rate of weight regain is significantly faster than ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight loss when taken correctly. The safety profile of GLP-1 pills largely mirrors ...